258 related articles for article (PubMed ID: 27093871)
21. Tibetan medicine Ru-yi-Zhen-bao Pills exhibits anti-migraine effect through mediating PAG anti-nociceptive channel.
Luo YM; Ren XQ; Yang XQ; Song HR; Li R; Gao MH; Li YR; Zhou RR; Ma L; Zhang SJ; Dong RJ; Ge DY; Wang CG; Ren QJ; Tao XH
J Ethnopharmacol; 2020 Mar; 249():112437. PubMed ID: 31794788
[TBL] [Abstract][Full Text] [Related]
22. Dimethyl fumarate alleviates the nitroglycerin (NTG)-induced migraine in mice.
Casili G; Lanza M; Filippone A; Campolo M; Paterniti I; Cuzzocrea S; Esposito E
J Neuroinflammation; 2020 Feb; 17(1):59. PubMed ID: 32066464
[TBL] [Abstract][Full Text] [Related]
23. Nitroglycerin-induced changes in facial skin temperature: 'cold nose' as a predictor of headache?
Zaproudina N; Närhi M; Lipponen JA; Tarvainen MP; Karjalainen PA; Karhu J; Airaksinen O; Giniatullin R
Clin Physiol Funct Imaging; 2013 Nov; 33(6):409-17. PubMed ID: 23701267
[TBL] [Abstract][Full Text] [Related]
24. Protein kinase Cδ as a neuronal mechanism for headache in a chronic intermittent nitroglycerin model of migraine in mice.
He Y; Shi Z; Kashyap Y; Messing RO; Wang ZJ
Pain; 2021 Oct; 162(10):2499-2511. PubMed ID: 34108435
[TBL] [Abstract][Full Text] [Related]
25. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs.
Iversen HK; Olesen J
Cephalalgia; 1996 Oct; 16(6):412-8. PubMed ID: 8902249
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology of reflex blinks in the rat: a novel model for headache research.
Jones MG; Andreou AP; McMahon SB; Spanswick D
J Headache Pain; 2016 Dec; 17(1):96. PubMed ID: 27770405
[TBL] [Abstract][Full Text] [Related]
27. Cortical spreading depolarisation-induced facial hyperalgesia, photophobia and hypomotility are ameliorated by sumatriptan and olcegepant.
Tang C; Unekawa M; Kitagawa S; Takizawa T; Kayama Y; Nakahara J; Shibata M
Sci Rep; 2020 Jul; 10(1):11408. PubMed ID: 32651400
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the use of sumatriptan-naproxen sodium for menstrual migraine and dysmenorrhea.
Allais G; Castagnoli Gabellari I; Rolando S; Benedetto C
Expert Rev Neurother; 2011 Oct; 11(10):1383-7. PubMed ID: 21955195
[TBL] [Abstract][Full Text] [Related]
29. Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraine.
Cady RK; Munjal S; Cady RJ; Manley HR; Brand-Schieber E
J Headache Pain; 2017 Dec; 18(1):17. PubMed ID: 28176235
[TBL] [Abstract][Full Text] [Related]
30. Sumatriptan succinate : pharmacokinetics of different formulations in clinical practice.
Lionetto L; Negro A; Casolla B; Simmaco M; Martelletti P
Expert Opin Pharmacother; 2012 Nov; 13(16):2369-80. PubMed ID: 23013035
[TBL] [Abstract][Full Text] [Related]
31. α6GABA
Tzeng HR; Lee MT; Fan PC; Knutson DE; Lai TH; Sieghart W; Cook J; Chiou LC
Neurotherapeutics; 2021 Jan; 18(1):569-585. PubMed ID: 33111258
[TBL] [Abstract][Full Text] [Related]
32. Exogenous Hsp70 attenuates nitroglycerin-induced migraine-like symptoms in mice.
Wu F; Huang Y; Wei G; Huang Z; Shi C; Lin W; Liao J
J Neurophysiol; 2021 Oct; 126(4):1030-1037. PubMed ID: 34469702
[TBL] [Abstract][Full Text] [Related]
33. Cilostazol induced migraine does not respond to sumatriptan in a double blind trial.
Falkenberg K; Dunga BÓÁ; Guo S; Ashina M; Olesen J
J Headache Pain; 2018 Feb; 19(1):11. PubMed ID: 29396788
[TBL] [Abstract][Full Text] [Related]
34. Microglia P2X4 receptor contributes to central sensitization following recurrent nitroglycerin stimulation.
Long T; He W; Pan Q; Zhang S; Zhang Y; Liu C; Liu Q; Qin G; Chen L; Zhou J
J Neuroinflammation; 2018 Aug; 15(1):245. PubMed ID: 30165876
[TBL] [Abstract][Full Text] [Related]
35. Intranasal sumatriptan for acute migraine attacks: a systematic review and meta-analysis.
Menshawy A; Ahmed H; Ismail A; Abushouk AI; Ghanem E; Pallanti R; Negida A
Neurol Sci; 2018 Jan; 39(1):31-44. PubMed ID: 28942578
[TBL] [Abstract][Full Text] [Related]
36. Analgesia effect of baicalein against NTG-induced migraine in rats.
Zhang XF; Zhang WJ; Dong CL; Hu WL; Sun YY; Bao Y; Zhang CF; Guo CR; Wang CZ; Yuan CS
Biomed Pharmacother; 2017 Jun; 90():116-121. PubMed ID: 28343071
[TBL] [Abstract][Full Text] [Related]
37. Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from pain.
Silberstein SD; Newman LC; Marmura MJ; Nahas SJ; Farr SJ
Curr Med Res Opin; 2013 Jul; 29(7):861-7. PubMed ID: 23514092
[TBL] [Abstract][Full Text] [Related]
38. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
[TBL] [Abstract][Full Text] [Related]
39. Nitroglycerin challenge induces lateralized headache in nasociliarynerve-ligated rats: implications for chronic migraine.
Akçali D; Belen AD; Babacan A; Bolay H
Turk J Med Sci; 2017 Apr; 47(2):681-688. PubMed ID: 28425266
[TBL] [Abstract][Full Text] [Related]
40. IL-17 crosses the blood-brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine.
Chen H; Tang X; Li J; Hu B; Yang W; Zhan M; Ma T; Xu S
J Headache Pain; 2022 Jan; 23(1):1. PubMed ID: 34979902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
